How to Commercialize a Patent in Nepal: The Five Routes and the DOI Paperwork
How to commercialize a patent in Nepal: working it, licensing, assignment, joint ventures and importation — the deal structures, DOI recordals and fees.
A registration certificate is not a revenue line. The Nepalese patent that sits framed above the founder's desk while nothing is manufactured, licensed or sold is an asset depreciating in annual maintenance fees — NPR 5,000 to 7,500 a year — with a compulsory-licensing question attached to its idleness.
Commercializing a patent in Nepal runs through five routes, each with its own deal structure and its own paperwork at the Department of Industry.
In short
To commercialize a patent in Nepal, choose the route that matches your capital and control appetite: work the invention yourself (manufacture, sell or import under the patent); license it (exclusive or non-exclusive, in writing, with royalties and a DOI recordal); assign it outright (written assignment recorded at the DOI — NPR 5,000 at current rates); contribute it to a joint venture (where dissolution clauses decide who keeps what); or let a licensee import goods working the patent. Nepal's 7-year renewable terms and annual maintenance make timing structural: deals should be timed against the renewal calendar, and an unworked patent invites compulsory-licensing exposure while bleeding fees.
Commercialize a patent in Nepal, route one: work it yourself
The simplest route is the one the fee schedule quietly encourages: make it, sell it, or import goods working the patent under your own control. Exclusivity is what the registration grants — the right to exclude others from the invention in Nepal — and the patentee who exercises it converts NPR 5,000-a-year maintenance into a defensible margin.
Working the invention also matters defensively. Nepalese patent law contemplates compulsory licensing where patented inventions are not worked — the site's compulsory-licensing guide covers the grounds — and an idle patent is exposed on that axis as well as being pure cost. Keep the working evidence: production records, sales, import documents under the patent.
Route two: licence it
A licence lets someone else work the invention while you keep ownership: a Nepali manufacturer taking production, a distributor taking the finished device, a regional partner taking the technology abroad. The structural choice is exclusive versus non-exclusive — exclusivity commands higher royalties but forecloses the field; non-exclusive licensing stacks smaller streams across several licensees.
The licence must be in writing, with scope (fields of use, territory, term), royalty structure (running royalty, minimums, milestones), quality control where the patentee's reputation attaches, and improvement clauses. Record the licence at the DOI so the register shows the encumbrance — unrecorded licences surface as disputes in diligence, and foreign payers' royalty repatriation runs through NRB-approved, recorded structures under FITTA.
Route three: assign it
Assignment sells the patent outright: the buyer steps into the patentee's position for the remaining term — which, on Nepal's 7+7+7 structure, may be anything from months to two decades. Price follows the remaining term, the maintenance status, and whether the invention is being worked.
The mechanics are unforgiving in one detail: the assignment must be recorded at the DOI to be effective against third parties — NPR 5,000 per patent at current rates. Nepalese IP history is littered with deals where the money moved and the recordal did not, leaving the 'buyer' enforcing rights that legally remained the seller's. The recordal receipt is the closing document that matters.
| Route | DOI paperwork | Revenue shape | Key risk |
|---|---|---|---|
| Work it yourself | None — keep use evidence | Product margin over the term | Manufacturing capital and execution |
| Licence (exclusive) | Licence recordal | Higher royalty, single stream | Licensee underperformance |
| Licence (non-exclusive) | Licence recordal per deal | Stacked smaller streams | Channel conflict |
| Assign | Assignment recordal (NPR 5,000) | Lump sum, once | Pricing the remaining term |
| Joint venture | Contribution + recordal chain | Shared venture returns | Dissolution ownership fights |
Routes four and five: the joint venture and the importing licensee
A joint venture can receive the patent as a capital contribution — the IP due diligence question then becomes who keeps it at dissolution, and the answer lives in the JV agreement's exit clauses, drafted before the money does. Nepal's joint-venture dissolution record on this point is cautionary: partners who never specified the IP's fate litigated for it.
The quiet fifth route is the importing licensee: for inventions you cannot manufacture in Nepal economically, a licence that lets the licensee import goods working the patent is still commercialisation — and it still counts as working the invention, with the licence paper to prove it.
Timing deals against the renewal calendar
Nepal's term structure makes timing structural, not tactical. A patent in its first term with two renewals available is priced differently from one entering its final years; a deal signed in month 30 of a 7-year term should account for who pays the annual maintenance during the licence; and a sale in the year before a renewal window should settle who bears the lapse risk. Buyers' diligence reads the register and the renewal receipts — sellers who arrive with both current negotiate from strength.
Audit before you deal
Renewals current, register details accurate, any earlier licences or encumbrances mapped.
Match the route to the capital
Manufacturing capital for route one; licensing for royalty income; assignment for exit.
Paper and record the transfer
Written licence or assignment, then the DOI recordal — the receipt closes the deal.
Re-time against the calendar
Renewal windows and remaining term decide both price and negotiating posture.
Want this handled for your brand?
IP Watch monitors new trademark publications in Nepal and alerts you to potentially conflicting marks — with the context needed to review them.
This article is general information, not legal advice.